Polaryx Therapeutics
(NASDAQ) PLYX
Polaryx Therapeutics Financials at a Glance
Market Cap
$368.80M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.98M
EPS (TTM)
$-0.19
P/E Ratio
-41.04
Dividend
$0.00
Beta (Volatility)
-1.11 (Low)
Dividend
$0.00
Beta (Volatility)
-1.11 (Low)
Price
$7.84
Volume
32,107
Open
$6.44
Price
$7.84
Volume
32,107
Open
$6.44
Previous Close
$7.79
Daily Range
$6.34 - $9.18
52-Week Range
$2.20 - $48.91
Dividend
$0.00
Beta (Volatility)
-1.11 (Low)
Price
$7.84
Volume
32,107
Open
$6.44
Previous Close
$7.79
Daily Range
$6.34 - $9.18
52-Week Range
$2.20 - $48.91
PLYX News
PLYX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Polaryx Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
11
CEO
Alex Yang
Website
www.polaryx.comHeadquarters
Paramus, NJ 07652, US
PLYX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-194%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-2.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$368.80M
Shares Outstanding
47.34M
Volume
32.11K
Short Interest
0.00%
Avg. Volume
2.71M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$7.82M
EBITDA
$7.82M
Operating Cash Flow
$3.94M
Capital Expenditure
$0.00
Free Cash Flow
$3.94M
Cash & ST Invst.
$5.14M
Total Debt
$0.00
Polaryx Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$368.80M
N/A
Market Cap/Employee
$33.53M
N/A
Employees
11
N/A
Net Income
$1.50M
-106.8%
EBITDA
$911.00K
-26.0%
Quarterly Fundamentals
Net Cash
$5.14M
+11.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.66%
N/A
Return on Invested Capital
-1.62%
N/A
Free Cash Flow
$1.49M
N/A
Operating Cash Flow
$1.49M
N/A